Navigation Links
BioMed Realty Trust to Report 2011 Fourth Quarter and Year End Results
Date:1/31/2012

SAN DIEGO, Jan. 31, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its fourth quarter and year ended December 31, 2011 after the market closes on Wednesday, February 8, 2012.

Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Thursday, February 9, 2012 to discuss the company's financial results and operations for the year.

The call will be open to all interested investors either through a live audio web cast at the Investor Relations section of the company's web site at www.biomedrealty.com and at www.earnings.com, which will include an online slide presentation to accompany the call, or live by calling 866-730-5765 (domestic) or 857-350-1589 (international) with call ID number 58496845. The complete webcast will be archived for 30 days on both web sites. A telephone playback of the conference call will also be available from 1:00 p.m. Pacific Time on Thursday, February 9, 2012 until midnight Pacific Time on Tuesday, February 14, 2012 by calling 888-286-8010 (domestic) or 617-801-6888 (international) and using access code 27497353.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in properties comprising approximately 12.4 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Francisco, Maryland, San Diego, New York/New Jersey, Pennsylvania and Seattle, which have well-established reputations as centers for scientific research.  Additional information is available at www.biomedrealty.com.

CONTACT: Rick Howe
Director, Corporate Communications
(858) 207 – 5859


'/>"/>
SOURCE BioMed Realty Trust, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ZyGEM to Provide its Unique DNA and RNA Extraction Technology to Middle East Biomedical Innovator Saudi Diagnostics Ltd.
2. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
3. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
4. Live Press Briefing on Findings of Biomedical Industry CEO Survey
5. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
6. BioMed Realty Trust Declares Fourth Quarter 2011 Common Stock and Preferred Stock Dividends
7. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
8. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
9. Webcor Builders Selected as the General Contractor for First Phase of LA BioMeds New Campus Master Plan
10. Saladax Biomedical, Inc. Appoints Li Zhang, M.D., to Scientific Advisory Board
11. Advanced BioMedical Technologies Inc. Announces Formation of Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Feb. 24, 2017 Symic Bio, a biopharmaceutical ... new category of therapeutics, announced today the completion of ... peripheral artery disease. The trial will evaluate the safety ... in the reduction of restenosis following angioplasty. ... milestone for SB-030," said Nathan Bachtell , M.D., ...
(Date:2/24/2017)... -- China Cord Blood Corporation (NYSE: CO ... cord blood collection, laboratory testing, hematopoietic stem cell processing ... financial results for the third quarter and first nine ... Third Quarter of Fiscal 2017 Highlights ... 2017 increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the ... today announced its financial results for the fourth quarter and ... Financial Highlights Total sales in the ... or increased by 13.6% in USD terms to $77.6 million ... Gross profit increased by 13.3% to $46.8 million ...
(Date:2/24/2017)... SAN DIEGO , Feb. 24, 2017  OncoSec ... intratumoral cancer immunotherapies, will host a Key Opinion Leader ... featured as an oral and poster presentation at the ... development plan. The KOL event will be held in-person ... 12:00 PM EST / 9:00 AM PST at the ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 8, 2017 About Voice Recognition ... to match it against a stored voiceprint template. ... pitch, cadence, and tone are compared to distinguish ... hardware installation, as most PCs already have a ... transactions. Voice recognition biometrics are most likely to ...
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/6/2017)... DENVER , Feb. 6, 2017 ... national security are driving border authorities to continue ... Acuity reports there are 2143 Automated Border Control ... Kiosks currently deployed at more than 163 ports ... between 2013 to 2016 achieving a combined CAGR ...
Breaking Biology News(10 mins):